There is a consensus that fee-for-service reimbursement does too little to encourage the provision of high-value care. Our Enterprise, an integrated payer-provider based in Pittsburgh, created an alternative compensation model for endocrinologists. Our plan introduces a gradual shift in the role of endocrinologists from clinical duties to a more collaborative role with their primary care colleagues. Considering that most patients with diabetes are managed under primary care, this shift allows endocrinologists to support primary care physicians (PCPs) in managing patients with diabetes and other endocrine-related illnesses while decreasing the number of traditional in-office referrals to endocrinology. Despite the unexpected changes brought on by COVID, in first 9 months of the compensation model, we observed its impact on care delivery as well as the relationship between participating specialists and PCPs. Practice- and provider-level quality data has shown improvement in diabetes-specific quality metrics. In one year, 16 out of 54 target practices earned NCQA recognition for diabetes management. A total of 88% of participating PCPs reported a satisfaction score > 90% with the new plan. Ultimately, our model shows promise as a replacement for fee-for-service compensation, with a likelihood of lowering costs and improved quality of care.